Reducing the risk of transmitting genital herpes: advances in understanding and therapy

References

• Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337:1105–11
   PubMed Web of Science ®Google Scholar
• Corey L, Handsfield HH. Genital herpes and public health: Addressing a global problem. JAMA 2000;283:791–4
   PubMed Web of Science ®Google Scholar
• Hayden RG, Antimicrobial Agents. In: Hardman JG, Limbird LE, Eds. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 2001: McGraw-Hill, New York, 1313–48
   Google Scholar
• Drake S, Taylor S, Brown D, et al. Improving the care of patients with genital herpes. BMJ 2000;321:619–23
   PubMed Web of Science ®Google Scholar
• The Henry J. Kaiser Foundation web site. Sexually transmitted diseases in America: how many cases and at what cost? December 1998;1–13. Available at www.kff.org/content/archive/1445/std_ rep.pdf [Accessed 5 February 2003]
   Google Scholar
• Leone P, Fleming D, Gilsenan AW, et al. Seroprevalence of herpes simplex virus-2 in suburban primary care offices in the United States. Sex Trans Dis 2004;31:311–03
   PubMed Web of Science ®Google Scholar
• Conant MA, Berger TG, Coates TJ, et al. Genital herpes: an integrated approach to management. J Am Acad Dermatol 1996;35:601–5
   PubMed Web of Science ®Google Scholar
• Corey L, Adams HG, Brown ZA, et al. Genital herpes simplex virus infections: Clinical manifestations, course and complications. Ann Intern Med 1982;98:958–72
   Web of Science ®Google Scholar
• Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 1994;121:847–54
   Google Scholar
• Wald A, Zeh J, Selke S, et al. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995;333:770–5
   PubMed Web of Science ®Google Scholar
• Bierman SM. Recurrent genital herpes simplex infection: A trivial disorder. Arch Dermatol 1985;121:513–7
   PubMed Web of Science ®Google Scholar
• VanderPlate C, Aral SO. Psychosocial aspects of genital herpes virus infection. Health Psychol 1987;6:57–72
   PubMed Web of Science ®Google Scholar
• Green J, Kocsis A. Psychological factors in recurrent genital herpes. Genitourin Med 1997;73:253–8
   PubMedGoogle Scholar
• Mindell A. Psychological and psychosexual implications of herpes simplex virus infections. Scan J Infect Dis Suppl 1996;100: 27–32
   PubMedGoogle Scholar
• Celum CL. The interaction between herpes simplex virus and human immunodeficiency virus. Herpes 2004;11 (Suppl 1): 36A–45A
   Google Scholar
• Marques AR, Straus SE. Herpes simplex type 2 infections – an update. DM 2000;46:327–59
   Web of Science ®Google Scholar
• Whitley RJ. Neonatal herpes simplex virus infections: pathogenesis and therapy. Pathol Biol 1992;40:729–34
   PubMed Web of Science ®Google Scholar
• Arvin AM, Prober CG. Herpes simplex virus type 2 – a persistent problem. N Engl J Med 1997;337:1158–9
   PubMed Web of Science ®Google Scholar
• Patel R, Cowan FM, Barton SE. Advising patients with genital herpes: acyclovir reduces asymptomatic viral shedding, but effect on transmission is unclear. BMJ 1997;314:85–6
   Google Scholar
• Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000;342:844–50
   PubMed Web of Science ®Google Scholar
• Koelle DM, Wald A. Herpes simplex virus: the importance of asymptomatic shedding. J Antimicrob Chemother 2000; 45:1–8
   PubMed Web of Science ®Google Scholar
• Mertz GJ, Benedetti J, Ashley R, et al. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992;116:197–202
   PubMed Web of Science ®Google Scholar
• Wald A. Herpes. Transmission and viral shedding. Dermatol Clin 1998;16:795–7
   PubMed Web of Science ®Google Scholar
• Wald A, Corey L, Cone R, et al. Frequent genital herpes simplex virus 2 shedding in immunocompetent women: effect of acyclovir treatment. J Clin Invest 1997;99:1092–7
   PubMed Web of Science ®Google Scholar
• Bryson Y, Dillon M, Bernstein DI, et al. Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis 1993;167:942–6
   PubMed Web of Science ®Google Scholar
• Mertz GJ, Schmidt O, Jourden JL, et al. Frequency of acquisition of first episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Trans Dis 1985; 12:33–9
   PubMed Web of Science ®Google Scholar
• Koelle DM, Benedetti J, Langenberg A, et al. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes. Ann Intern Med 1992;116:433–7
   PubMed Web of Science ®Google Scholar
• Wald A, Zeh J, Barnum G, et al. Suppression of asymptomatic shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 1996;124:8–15
   PubMed Web of Science ®Google Scholar
• Gupta R, Wald A, et al. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. J Infect Dis 2004;190:1374–81
   PubMed Web of Science ®Google Scholar
• Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004;350:11–20
   PubMed Web of Science ®Google Scholar
• Wald A, Zeh J, Selke S, et al. Genital shedding of herpes simplex virus among men. J Infect Dis 2002;186:S34–S39
   PubMed Web of Science ®Google Scholar
• Rooney JF, Felser JM, Ostrover JM, et al. Acquisition of genital herpes from an asymptomatic sexual partner. N Engl J Med 1986;314:1561–4
   PubMed Web of Science ®Google Scholar
• Wald A, Langenberg AGM, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001;285:3100–6
   PubMed Web of Science ®Google Scholar
• Corey L, Langenberg AGM, Ashley R. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. JAMA 1999;282: 331–40
   Google Scholar
• Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein- D-adjuvant vaccine to prevent genital herpes. N Eng J Med 2002;347:1652–61
   PubMed Web of Science ®Google Scholar